Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis

Tumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC). We conducted this systematic review and meta-analysis to assess whether blood can...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Mao, Chen, Yuan, Jin-Qiu, Yang, Zu-Yao, Fu, Xiao-Hong, Wu, Xin-Yin, Tang, Jin-Ling
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2015
Subjects:
5700
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616411/
https://ncbi.nlm.nih.gov/pubmed/26020382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000775
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items